Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

AbstractLong-term and rare adverse effects of COVID-19 vaccines are unknown. Hence, it is important to report them to improve the safety profile of the vaccines and enhance their use worldwide. Here, we  describes a case of acute visual impairment after Pfizer-BioNTech vaccine second dose. 
Source: Inflammation Research - Category: Research Source Type: research
More News: COVID-19 | Pfizer | Research | Vaccines